Clinical Trial Update: Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing darbepoetin alfa with recombinant human erythropoietin for treating anemia in children with chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Recombinant human erythropoietin (erythropoietin)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Rufaida Mazahir | Conditions: Anemia of Chronic Kidney Disease | Phase 4 | Status: COMPLETED